未适应高海拔救援者的药物预防与补氧:范围综述及2025年国际山地急诊医学委员会与国际山地医学学会联合推荐
该范围综述按PRISMA指南筛选723篇文献,最终纳入50篇(氧6篇、乙酰唑胺29篇、地塞米松17篇、硝苯地平3篇、磷酸二酯酶-5抑制剂5篇),聚焦未适应救援者快速升至3500米以上时补氧与药物预防对体能、认知及高山病的影响。推荐:3500至4000米间快速上升救援超过30分钟、或4000米以上任何时长救援使用补氧;给氧时无需药物预防;无氧时3500米以上超过3小时的快速上升救援可用乙酰唑胺或地塞米松减少急性高山病发生与严重程度;5000米以上或需长时间体力工作的救援推荐乙酰唑胺与地塞米松联用。
要点
- 3500至4000米间快速上升救援超过30分钟、或4000米以上任何时长救援,推荐补氧以改善体能与认知。
- 若已给氧,则不需要药物预防。
- 无氧时,3500米以上超过3小时的快速上升救援可用乙酰唑胺或地塞米松减少急性高山病发生与严重程度。
- 5000米以上或需长时间体力工作的救援,推荐乙酰唑胺与地塞米松联用。
- 救援者与飞行员快速升至3500米以上面临低氧血症所致认知与体能损害及高山病风险。
适用人群与场景
- 未适应的高海拔救援者与飞行员,快速升至3500米以上执行救援任务。
处置流程与药物剂量
- 3500至4000米间快速上升救援超过30分钟,推荐补氧。
- 4000米以上任何时长的救援,推荐补氧。
- 若给氧,则不需要药物预防。
- 无氧时,3500米以上超过3小时的快速上升救援,可用乙酰唑胺或地塞米松以减少急性高山病发生与严重程度。
- 5000米以上或需长时间体力工作的救援,推荐乙酰唑胺与地塞米松联用。
研究设计与关键结果
- 范围综述按PRISMA指南筛选723篇文献,审阅133篇,最终纳入50篇:氧6篇、乙酰唑胺29篇、地塞米松17篇、硝苯地平3篇、磷酸二酯酶-5抑制剂5篇。
- 补氧可改善高海拔体能与认知表现。
证据类型、等级与局限
- 证据类型:范围综述及国际学会联合推荐;方法遵循PRISMA指南。
- 局限:原文未报告局限性。
对床旁实践的改变
- 对快速升至3500米以上的未适应救援者,可按海拔与救援时长决定补氧或药物预防:3500至4000米超过30分钟或4000米以上任何时长推荐补氧。
- 无氧条件下,3500米以上超过3小时的快速上升救援可用乙酰唑胺或地塞米松;5000米以上或长时间体力工作时推荐两药联用。
指南或共识出处
- 国际山地急诊医学委员会(International Commission for Mountain Emergency Medicine)与国际山地医学学会(International Society for Mountain Medicine)2025年联合推荐,发表于High Alt Med Biol 2026;27:60-77。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
UNLABELLED: McLaughlin, Kyle, Steve Roy, Marika Falla, Giacomo Strapazzon, Andrew M. Luks, Ken Zafren, Hermann Brugger, Martin Musi, Iztok Tomazin, John Ellerton, Ghan Bahadur Thapa, and Peter Paal. Pharmacological prophylaxis and supplemental oxygen for unacclimatized rescuers at very high altitude: scoping review and 2025 joint recommendations of the International Commission for Mountain Emergency Medicine and the International Society for Mountain Medicine. High Alt Med Biol. 27:60-77, 2026.
BACKGROUND: Mountain rescuers and pilots rapidly ascending to altitudes above 3,500 m are exposed to the detrimental effects of hypobaric hypoxia, including cognitive and physical impairment, as well as high-altitude illness (HAI). We conducted a scoping review of oxygen supplementation and pharmacologic measures to improve cognitive and physical performance and prevent HAI in unacclimatized rescuers rapidly ascending above 3,500 m during rescue missions.
METHODS: Following Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, 723 articles were screened, 133 reviewed and a total of 50 articles were included for data extraction, based on the intervention: 6 on oxygen, 29 on acetazolamide (AZ), 17 on dexamethasone (DEX), 3 on nifedipine, and 5 on phosphodiesterase-5 inhibitors.
DISCUSSION: Supplemental oxygen improves physical and cognitive performance at high altitude and is recommended for rapid ascent rescues >30 minutes between 3,500 and 4,000 m, and for rescues of any duration above 4,000 m. If oxygen is administered, pharmacological prophylaxis is not required. If oxygen is unavailable, AZ or DEX can be used for rapid ascent rescues above 3,500 m for longer than 3 hours to reduce the incidence and severity of acute mountain sickness. At altitudes above 5,000 m or for rescues requiring prolonged physical work, the use of both AZ and DEX is recommended.
CONCLUSIONS: To enhance the safety and effectiveness of high-altitude rescues, we provide recommendations for the use of supplemental oxygen and pharmacologic prophylaxis to reduce the risk of HAI and improve cognitive and physical performance during rapid ascents to altitudes >3,500 m.
参考来源
- McLaughlin K, Roy S, Falla M, et al. Pharmacological Prophylaxis and Supplemental Oxygen for Unacclimatized Rescuers at Very High Altitude: Scoping Review and 2025 Joint Recommendations of the International Commission for Mountain Emergency Medicine and the International Society for Mountain Medicine. High Alt Med Biol. 2026. PMID: 40844506. doi:10.1177/15578682251365931
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。